Digital AI in drug development: The real hurdle is implementation Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.
Digital Patients as active consumers of care: AI-driven personalisat... In a new podcast, web editor Nicole Raleigh speaks with Bill Grambley, CEO of AllazoHealth, for a conversation on leveraging AI for marketing.
Digital GenAI and the revolution of drug development Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.
Digital Simulated clinical trial populations and AI scalability AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical.
Digital From science fiction to reality: AI in drug development In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Isaac Bentwich, CEO and founder of Quris.AI.
Digital Seeking effective, safe treatment for all with precision dos... Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paedi
Oncology In pursuit of a cure for cancer: An ASCO 2025 discussion wit... Dr Danny Nguyen, medical oncologist and haematologist at the City of Hope Orange County, spoke with pharmaphorum at ASCO 2025.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face